Only half of colorectal-cancer patients elicit serum antibodies in response to intratumoral p53-gene mutations. Our study was designed to compare cellular events (p53-protein accumulation and gene mutations) with the presence of circulating anti-p53 antibodies (p53-Ab). Thirty-five colorectalcancer
p53 protein accumulation and mutations in normal and benign breast tissue
β Scribed by Rita Kandel; Shu-Qiu Li; Hilmi Ozcelik; Tom Rohan
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 154 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: P53 gene mutation and p53 protein accumulation are common in human cancer. however, their clinical significance is controversial and p53 accumulation may not correlate with gene mutation. the current study investigates the occurrence of p53 alterations in esophageal carcinoma, the co
Mutations of the tumor-suppressor gene p53 are common in epithelial tumors. Clonal mutations of p53 have been found in cervical and vulvar carcinomas negative for human papillomavirus (HPV), though at least in cervical cancer HPV infection and p53 mutations are not mutually exclusive. We have previo
Radiation used in breast-conserving therapy (BCT) for early breast cancer, to eradicate residual malignant cells after tumour resection, induces DNA damage and cell death. Little is known about the effect of the commonly used doses of radiation therapy on normal breast tissue. Under physiological co
Background and Objectives: We investigated whether expression levels of c-erbB-2 and p53 proteins in breast cancer tissues differ in primary and metastatic lesions. Methods: Immunohistochemical staining or sandwich enzyme immunoassay was used to determine expression levels of c-erbB-2 and p53 protei